Test for tables on Yahoo 51965319
Test for tables on Yahoo 51965319
SF--(BUSINESS WIRE)--test - ignore
test1 word table
WHAT |
WHEN & WHERE |
The Happening
feat.
|
1:00 p.m. Eastern The Lounge 101 California St. San Francisco, CA 94111
|
test2 financial table w/ alternating row color (blue)
XYZ CORPORATION | ||||||||||
Consolidated Income Statements | ||||||||||
(in thousands, except per share amounts) | ||||||||||
Unaudited | ||||||||||
Three Months Ended | Nine Months Ended | |||||||||
September 30, | September 30, | September 30, | September 30, | |||||||
|
2006 |
|
|
2005 |
|
2006 |
|
|
2005 |
|
Revenues: | ||||||||||
Product sales | $ |
2,035,652 |
|
$ |
1,687,277 |
$ |
5,717,780 |
|
$ |
4,996,110 |
Services |
|
779,654 |
|
|
678,465 |
|
2,222,736 |
|
|
1,957,578 |
|
2,815,306 |
|
|
2,365,742 |
|
7,940,516 |
|
|
6,953,688 |
|
Cost and expenses: | ||||||||||
Cost of product sales |
|
992,272 |
|
|
813,760 |
|
2,794,910 |
|
|
2,425,379 |
Cost of services |
|
339,295 |
|
|
274,365 |
|
970,532 |
|
|
819,829 |
Research and development |
|
312,302 |
|
|
254,720 |
|
895,220 |
|
|
742,359 |
Selling, general and administrative |
|
809,086 |
|
|
641,219 |
|
2,339,326 |
|
|
1,899,619 |
In-process research and development |
|
23,000 |
|
|
- |
|
35,410 |
|
|
3,100 |
Restructuring charges (credits) |
|
(2,779 |
) |
|
5,849 |
|
(4,359 |
) |
|
3,717 |
Operating income |
|
342,130 |
|
|
375,829 |
|
909,477 |
|
|
1,059,685 |
test3 financial table w/out row color, no border
XYZ CORPORATION | ||||||||||
Consolidated Income Statements | ||||||||||
(in thousands, except per share amounts) | ||||||||||
Unaudited | ||||||||||
Three Months Ended | Nine Months Ended | |||||||||
September 30, | September 30, | September 30, | September 30, | |||||||
|
2006 |
|
|
2005 |
|
2006 |
|
|
2005 |
|
Revenues: | ||||||||||
Product sales | $ |
2,035,652 |
|
$ |
1,687,277 |
$ |
5,717,780 |
|
$ |
4,996,110 |
Services |
|
779,654 |
|
|
678,465 |
|
2,222,736 |
|
|
1,957,578 |
|
2,815,306 |
|
|
2,365,742 |
|
7,940,516 |
|
|
6,953,688 |
|
Cost and expenses: | ||||||||||
Cost of product sales |
|
992,272 |
|
|
813,760 |
|
2,794,910 |
|
|
2,425,379 |
Cost of services |
|
339,295 |
|
|
274,365 |
|
970,532 |
|
|
819,829 |
Research and development |
|
312,302 |
|
|
254,720 |
|
895,220 |
|
|
742,359 |
Selling, general and administrative |
|
809,086 |
|
|
641,219 |
|
2,339,326 |
|
|
1,899,619 |
In-process research and development |
|
23,000 |
|
|
- |
|
35,410 |
|
|
3,100 |
Restructuring charges (credits) |
|
(2,779 |
) |
|
5,849 |
|
(4,359 |
) |
|
3,717 |
Operating income |
|
342,130 |
|
|
375,829 |
|
909,477 |
|
|
1,059,685 |
test4 very wide financial table w/ alt row color (grey)
Testing wide table - financial alignment but no additional empty columns intentionally
WIDE TABLE TEST RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (UNAUDITED, IN THOUSANDS) |
|||||||||||||||||||||||||||||||||||
|
Nine months ended September 30, 2024 |
||||||||||||||||||||||||||||||||||
|
GAAP amount |
Adjustments |
Adjusted non-GAAP amount |
||||||||||||||||||||||||||||||||
|
Interest, net |
(Gain) loss on sale of business |
(Gain) loss on investments, net |
(Income) loss from equity method investments, net |
Amortization |
Share-based compensation |
Acquisition, integration, and other costs |
Disposal related costs |
Lease asset impairments and other charges |
Goodwill impairment on business |
|||||||||||||||||||||||||
Direct costs |
$ |
(152,900 |
) |
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
246 |
|
$ |
191 |
|
$ |
335 |
|
$ |
— |
|
$ |
— |
|
$ |
— |
$ |
(152,128 |
) |
Sales and marketing |
$ |
(369,184 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
2,865 |
|
|
5,706 |
|
|
— |
|
|
— |
|
|
— |
$ |
(360,613 |
) |
Research, development, and engineering |
$ |
(49,824 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
2,930 |
|
|
2,590 |
|
|
40 |
|
|
— |
|
|
— |
$ |
(44,264 |
) |
General, administrative, and other related costs |
$ |
(296,558 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
82,537 |
|
|
24,647 |
|
|
8,177 |
|
|
511 |
|
|
1,370 |
|
|
— |
$ |
(179,316 |
) |
Goodwill impairment on business |
$ |
(85,273 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
85,273 |
$ |
— |
|
Interest expense, net |
$ |
(7,597 |
) |
|
96 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
$ |
(7,501 |
) |
Loss on sale of business |
$ |
(3,780 |
) |
|
— |
|
|
3,780 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
$ |
— |
|
Loss on investments, net |
$ |
(7,654 |
) |
|
— |
|
|
— |
|
|
7,654 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
$ |
— |
|
Other income (loss), net |
$ |
2,530 |
|
|
— |
|
|
(4,903 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(537 |
) |
|
— |
|
|
— |
|
|
— |
$ |
(2,910 |
) |
Income tax expense |
$ |
(27,760 |
) |
|
(24 |
) |
|
1,226 |
|
|
(577 |
) |
|
— |
|
|
(20,771 |
) |
|
(4,798 |
) |
|
(4,731 |
) |
|
(94 |
) |
|
(332 |
) |
|
— |
$ |
(57,861 |
) |
Income from equity method investment, net |
$ |
8,095 |
|
|
— |
|
|
— |
|
|
— |
|
|
(8,095 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
$ |
— |
|
Total non-GAAP adjustments |
|
$ |
72 |
|
$ |
103 |
|
$ |
7,077 |
|
$ |
(8,095 |
) |
$ |
62,012 |
|
$ |
25,835 |
|
$ |
11,540 |
|
$ |
457 |
|
$ |
1,038 |
|
$ |
85,273 |
|
|
(1) Adjusted effective tax rate was approximately 23.9% for the nine months ended September 30, 2024. The calculation is based on a ratio where the numerator is the adjusted income tax expense of $57,861 and the denominator is $242,133, which equals adjusted net income of $184,272 plus adjusted income tax expense. |
test5 very wide table w/out color
Testing wide table - financial alignment but no additional empty columns intentionally
WIDE TABLE TEST RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (UNAUDITED, IN THOUSANDS) |
|||||||||||||||||||||||||||||||||||
|
Nine months ended September 30, 2024 |
||||||||||||||||||||||||||||||||||
|
GAAP amount |
Adjustments |
Adjusted non-GAAP amount |
||||||||||||||||||||||||||||||||
|
Interest, net |
(Gain) loss on sale of business |
(Gain) loss on investments, net |
(Income) loss from equity method investments, net |
Amortization |
Share-based compensation |
Acquisition, integration, and other costs |
Disposal related costs |
Lease asset impairments and other charges |
Goodwill impairment on business |
|||||||||||||||||||||||||
Direct costs |
$ |
(152,900 |
) |
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
246 |
|
$ |
191 |
|
$ |
335 |
|
$ |
— |
|
$ |
— |
|
$ |
— |
$ |
(152,128 |
) |
Sales and marketing |
$ |
(369,184 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
2,865 |
|
|
5,706 |
|
|
— |
|
|
— |
|
|
— |
$ |
(360,613 |
) |
Research, development, and engineering |
$ |
(49,824 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
2,930 |
|
|
2,590 |
|
|
40 |
|
|
— |
|
|
— |
$ |
(44,264 |
) |
General, administrative, and other related costs |
$ |
(296,558 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
82,537 |
|
|
24,647 |
|
|
8,177 |
|
|
511 |
|
|
1,370 |
|
|
— |
$ |
(179,316 |
) |
Goodwill impairment on business |
$ |
(85,273 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
85,273 |
$ |
— |
|
Interest expense, net |
$ |
(7,597 |
) |
|
96 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
$ |
(7,501 |
) |
Loss on sale of business |
$ |
(3,780 |
) |
|
— |
|
|
3,780 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
$ |
— |
|
Loss on investments, net |
$ |
(7,654 |
) |
|
— |
|
|
— |
|
|
7,654 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
$ |
— |
|
Other income (loss), net |
$ |
2,530 |
|
|
— |
|
|
(4,903 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(537 |
) |
|
— |
|
|
— |
|
|
— |
$ |
(2,910 |
) |
Income tax expense |
$ |
(27,760 |
) |
|
(24 |
) |
|
1,226 |
|
|
(577 |
) |
|
— |
|
|
(20,771 |
) |
|
(4,798 |
) |
|
(4,731 |
) |
|
(94 |
) |
|
(332 |
) |
|
— |
$ |
(57,861 |
) |
Income from equity method investment, net |
$ |
8,095 |
|
|
— |
|
|
— |
|
|
— |
|
|
(8,095 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
$ |
— |
|
Total non-GAAP adjustments |
|
$ |
72 |
|
$ |
103 |
|
$ |
7,077 |
|
$ |
(8,095 |
) |
$ |
62,012 |
|
$ |
25,835 |
|
$ |
11,540 |
|
$ |
457 |
|
$ |
1,038 |
|
$ |
85,273 |
|
|
(1) Adjusted effective tax rate was approximately 23.9% for the nine months ended September 30, 2024. The calculation is based on a ratio where the numerator is the adjusted income tax expense of $57,861 and the denominator is $242,133, which equals adjusted net income of $184,272 plus adjusted income tax expense. |
Contacts
contact